Stinchcombe TE. Flashback foreword: cisplatin/pemetrexed in non-small-cell lung cancer. J Clin Oncol. 2023;41(14):2455–6.

Article  PubMed  Google Scholar 

Patil VM, Noronha V, Menon N, et al. Results of phase III randomized trial for use of docetaxel as a radiosensitizer in patients with head and neck cancer, unsuitable for cisplatin-based chemoradiation. J Clin Oncol. 2023;41(13):2350–61.

Article  CAS  PubMed  Google Scholar 

Lin F, Li X, Wang X, et al. Stanniocalcin 1 promotes metastasis, lipid metabolism and cisplatin chemoresistance via the FOXC2/ITGB6 signaling axis in ovarian cancer. J Exp Clin Cancer Res. 2022;41(1):129.

Article  CAS  PubMed  PubMed Central  Google Scholar 

de Vries G, Rosas-Plaza X, van Vugt M, et al. Testicular cancer: determinants of cisplatin sensitivity and novel therapeutic opportunities. Cancer Treat Rev. 2020;88:102054.

Article  PubMed  Google Scholar 

Ghosh S. Cisplatin: the first metal based anticancer drug. Bioorg Chem. 2019;88: 102925.

Article  CAS  PubMed  Google Scholar 

Kong YW, Dreaden EC, Morandell S, et al. Enhancing chemotherapy response through augmented synthetic lethality by co-targeting nucleotide excision repair and cell-cycle checkpoints. Nat Commun. 2020;11(1):4124.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huntoon K, Toland AMS, Dahiya S. Meningioma: a review of clinicopathological and molecular aspects. Front Oncol. 2020;10: 579599.

Article  PubMed  PubMed Central  Google Scholar 

Ogasawara C, Philbrick BD, Adamson DC. Meningioma: a review of epidemiology, pathology, diagnosis, treatment, and future directions. Biomedicines. 2021;9(3):319.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Apra C, Peyre M, Kalamarides M. Current treatment options for meningioma. Expert Rev Neurother. 2018;18(3):241–9.

Article  CAS  PubMed  Google Scholar 

Sun SQ, Hawasli AH, Huang J, et al. An evidence-based treatment algorithm for the management of WHO Grade II and III meningiomas. Neurosurg Focus. 2015;38(3):E3.

Article  PubMed  Google Scholar 

Al-Khalaf HH, Lach B, Allam A, et al. Expression of survivin and p16(INK4a)/Cdk6/pRB proteins and induction of apoptosis in response to radiation and cisplatin in meningioma cells. Brain Res. 2008;1188:25–34.

Article  CAS  PubMed  Google Scholar 

Ference BA, Holmes MV, Smith GD. Using Mendelian randomization to improve the design of randomized trials. Cold Spring Harb Perspect Med. 2021;11(7):a040980.

Article  PubMed  PubMed Central  Google Scholar 

Mulford AJ, Wing C, Dolan ME, et al. Genetically regulated expression underlies cellular sensitivity to chemotherapy in diverse populations. Hum Mol Genet. 2021;30(3–4):305–17.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Burgess S, Thompson SG. Bias in causal estimates from Mendelian randomization studies with weak instruments. Stat Med. 2011;30(11):1312–23.

Article  PubMed  Google Scholar 

Hemani G, Bowden J, Haycock P, et al. Automating Mendelian randomization through machine learning to construct a putative causal map of the human phenome. BioRxiv. 2017;173682. [preprint]. Available from https://doi.org/10.1101/173682. Accessed 1 Apr 2024

Burgess S, Butterworth A, Thompson SG. Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol. 2013;37(7):658–65.

Article  PubMed  PubMed Central  Google Scholar 

Verbanck M, Chen CY, Neale B, et al. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat Genet. 2018;50(5):693–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yu C, Wang Z, Sun Z, et al. Platinum-based combination therapy: molecular rationale, current clinical uses, and future perspectives. J Med Chem. 2020;63(22):13397–412.

Article  CAS  PubMed  Google Scholar 

Richardson DL, Eskander RN, O’Malley DM. Advances in ovarian cancer care and unmet treatment needs for patients with platinum resistance: a narrative review. JAMA Oncol. 2023;9(6):851–9.

Article  PubMed  Google Scholar 

Amable L. Cisplatin resistance and opportunities for precision medicine. Pharmacol Res. 2016;106:27–36.

Article  CAS  PubMed  Google Scholar 

Sui Q, Chen Z, Hu Z, et al. Cisplatin resistance-related multi-omics differences and the establishment of machine learning models. J Transl Med. 2022;20(1):171.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang JL, Zhang ZJ, Hartman M, et al. Detection of TP53 gene mutation in human meningiomas: a study using immunohistochemistry, polymerase chain reaction/single-strand conformation polymorphism and DNA sequencing techniques on paraffin-embedded samples. Int J Cancer. 1995;64(4):223–8.

Article  CAS  PubMed  Google Scholar 

Liu X, Zhang H, Wang C, et al. Tumor-selective blockade of CD47 signaling with CD47 antibody for enhanced anti-tumor activity in malignant meningioma. Curr Neuropharmacol. 2023;21(10):2159–73.

Article  CAS  PubMed  PubMed Central  Google Scholar